Form 4 for SXTP 60 DEGREES PHARMACEUTICALS, INC.
Accepted 2024-05-21 00:00:00 ET · period of report 2023-12-31 · accession 0001213900-24-045706 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-21 | 2024-05-16 | SXTP | FIELD PAUL | Dir | M - OptEx | $0.22 | +4,000 | 14.0K | +40% | +$880 |
| D | 2024-05-21 | 2023-12-31 | SXTP | FIELD PAUL | Dir | A - Grant | $0.00 | +4,000 | 4,000 | New | $0 |
| D | 2024-05-21 | 2024-05-16 | SXTP | FIELD PAUL | Dir | M - OptEx | $0.00 | -4,000 | 4,000 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-16 | M | A | 4,000 | $0.22 | 14,000 | D | — | — | (F1) This transaction represents the settlement of restricted stock units in shares of common stock on May 16, 2024. |
| 2 | Derivative | Restricted Stock Units | 2023-12-31 | A | A | 4,000 | $0.00 | 4,000 | D | $0.00 · — to — | 4,000 Common Stock | (F2) Paul Field was initially granted a total of 8,000 restricted stock units ("RSUs") on July 11, 2023, of which were subsequently modified effective as of December 31, 2023 to 4,000 RSUs which were fully vested as of December 31, 2023. |
| 3 | Derivative | Restricted Stock Units | 2024-05-16 | M | D | 4,000 | $0.00 | 4,000 | D | $0.00 · — to — | 4,000 Common Stock | (F3) 4,000 shares underlying the RSUs were settled as of May 16, 2024. After the settlement of the shares of common stock that were underlying the 4,000 RSUs, Paul Field did not own any RSUs. |